https://www.marketscreener.com/quote/stock/TG-THERAPEUTICS-INC-13314736/news/TG-Therapeutics-Announces-Data-Presentations-from-the-ULTIMATE-I-II-Phase-3-Trials-of-Ublituximab-40551624/?utm_source=telegram&utm_medium=social&utm_campaign=share